Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

E-LEARNING MODULES

DCI delivers educational solutions for clients that enhance the business acumen of employees, from senior executives to field reps to internal operations. State-of-the-art instructional design, coupled with extensive industry knowledge, allows DCI to build rigorous programs with accurate, fact-based content reflecting the latest developments. Even better, we deliver the material in an engaging, accessible manner using turn-key technology solutions. View a sample of our modules

View Sample

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2025-26 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

REMS Removed: Why CAR-T’s Expansion into Community Oncology Could Benefit the Big Three Wholesalers

By Greis Kapexhiu and Adam J. Fein, Ph.D. In June 2025, the FDA announced that CAR-T therapies would no longer be subject to a REMS program. more >

Hub Transitions Need Proven Plans, Smart Scale-Up

Today's guest post comes from Josh Marsh, Vice President and General Manager at Cardinal Health Sonexus™ Access and Patient Support. Josh examines the risks manufacturers take more >